FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2057142441> ?p ?o ?g. }

• W2057142441 endingPage "316" @default.
• W2057142441 startingPage "301" @default.
• W2057142441 abstract "Comparative phase I clinical trials were carried out in 5 centres with three formulations of beta-hCG-based vaccines inducing antibodies against human chorionic gonadotropin. The objectives of these trials were to determine their relative immunogenicity, duration, reversibility and safety. A total of 116 tubal ligated women volunteers were enrolled in the study and 101 subjects were followed-up for one year or more until the antibody titres declined to near zero levels. Every woman receiving the vaccine produced anti-hCG and anti-tetanus antibodies. Clinical examination carried out at intervals of 4-6 weeks revealed no abnormality. No serious side effects or adverse reactions were reported with any of the formulations during primary immunization with three monthly injections of the vaccine. Eleven women, however, demonstrated hypersensitivity to test dose at the time of the booster injection. The reaction was to tetanus toxoid; gonadotropin subunits conjugated to another carrier did not evoke any such reaction. Progesterone in bleeds taken at midluteal phase, as well as complete progesterone and estradiol done in two immunized women, indicated normal ovulatory cycles. Immunization with these formulations had no significant effect on haematological, clinical chemistry and other metabolic parameters. In summary, the results indicate that none of the three beta-hCG-based contraceptive vaccines had any adverse effects clinically, on endocrine status and metabolic parameters. Formulations A and B induced comparatively higher anti-hCG titres than M. Thus, further work can be undertaken to study the efficacy of these vaccines in humans for preventing pregnancy." @default.
• W2057142441 created "2016-06-24" @default.
• W2057142441 creator A5002536724 @default.
• W2057142441 creator A5006431195 @default.
• W2057142441 creator A5006951839 @default.
• W2057142441 creator A5013292025 @default.
• W2057142441 creator A5016918523 @default.
• W2057142441 creator A5017758456 @default.
• W2057142441 creator A5018543701 @default.
• W2057142441 creator A5020604895 @default.
• W2057142441 creator A5024206707 @default.
• W2057142441 creator A5024745547 @default.
• W2057142441 creator A5025314832 @default.
• W2057142441 creator A5027768432 @default.
• W2057142441 creator A5030214838 @default.
• W2057142441 creator A5035036912 @default.
• W2057142441 creator A5042656337 @default.
• W2057142441 creator A5047290054 @default.
• W2057142441 creator A5053755550 @default.
• W2057142441 creator A5053790742 @default.
• W2057142441 creator A5072690619 @default.
• W2057142441 creator A5073833125 @default.
• W2057142441 creator A5075719247 @default.
• W2057142441 date "1990-03-01" @default.
• W2057142441 modified "2023-10-17" @default.
• W2057142441 title "Phase I clinical trials with three formulations of anti-human chorionic gonadotropin vaccine" @default.
• W2057142441 cites W1993120403 @default.
• W2057142441 cites W2023594183 @default.
• W2057142441 cites W2057407527 @default.
• W2057142441 cites W2069632874 @default.
• W2057142441 cites W2077005644 @default.
• W2057142441 cites W2100644767 @default.
• W2057142441 cites W2259753176 @default.
• W2057142441 cites W2285176942 @default.
• W2057142441 cites W2320887397 @default.
• W2057142441 doi "https://doi.org/10.1016/0010-7824(90)90071-3" @default.
• W2057142441 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/2182290" @default.
• W2057142441 hasPublicationYear "1990" @default.
• W2057142441 type Work @default.
• W2057142441 sameAs 2057142441 @default.
• W2057142441 citedByCount "61" @default.
• W2057142441 countsByYear W20571424412013 @default.
• W2057142441 countsByYear W20571424412014 @default.
• W2057142441 countsByYear W20571424412015 @default.
• W2057142441 countsByYear W20571424412016 @default.
• W2057142441 crossrefType "journal-article" @default.
• W2057142441 hasAuthorship W2057142441A5002536724 @default.
• W2057142441 hasAuthorship W2057142441A5006431195 @default.
• W2057142441 hasAuthorship W2057142441A5006951839 @default.
• W2057142441 hasAuthorship W2057142441A5013292025 @default.
• W2057142441 hasAuthorship W2057142441A5016918523 @default.
• W2057142441 hasAuthorship W2057142441A5017758456 @default.
• W2057142441 hasAuthorship W2057142441A5018543701 @default.
• W2057142441 hasAuthorship W2057142441A5020604895 @default.
• W2057142441 hasAuthorship W2057142441A5024206707 @default.
• W2057142441 hasAuthorship W2057142441A5024745547 @default.
• W2057142441 hasAuthorship W2057142441A5025314832 @default.
• W2057142441 hasAuthorship W2057142441A5027768432 @default.
• W2057142441 hasAuthorship W2057142441A5030214838 @default.
• W2057142441 hasAuthorship W2057142441A5035036912 @default.
• W2057142441 hasAuthorship W2057142441A5042656337 @default.
• W2057142441 hasAuthorship W2057142441A5047290054 @default.
• W2057142441 hasAuthorship W2057142441A5053755550 @default.
• W2057142441 hasAuthorship W2057142441A5053790742 @default.
• W2057142441 hasAuthorship W2057142441A5072690619 @default.
• W2057142441 hasAuthorship W2057142441A5073833125 @default.
• W2057142441 hasAuthorship W2057142441A5075719247 @default.
• W2057142441 hasConcept C12590561 @default.
• W2057142441 hasConcept C126322002 @default.
• W2057142441 hasConcept C131872663 @default.
• W2057142441 hasConcept C159654299 @default.
• W2057142441 hasConcept C197934379 @default.
• W2057142441 hasConcept C203014093 @default.
• W2057142441 hasConcept C22070199 @default.
• W2057142441 hasConcept C2775948956 @default.
• W2057142441 hasConcept C2777351567 @default.
• W2057142441 hasConcept C2778782382 @default.
• W2057142441 hasConcept C2779234561 @default.
• W2057142441 hasConcept C2779841045 @default.
• W2057142441 hasConcept C2780801004 @default.
• W2057142441 hasConcept C2780868878 @default.
• W2057142441 hasConcept C29456083 @default.
• W2057142441 hasConcept C42407357 @default.
• W2057142441 hasConcept C535046627 @default.
• W2057142441 hasConcept C54355233 @default.
• W2057142441 hasConcept C71315377 @default.
• W2057142441 hasConcept C71924100 @default.
• W2057142441 hasConcept C86803240 @default.
• W2057142441 hasConceptScore W2057142441C12590561 @default.
• W2057142441 hasConceptScore W2057142441C126322002 @default.
• W2057142441 hasConceptScore W2057142441C131872663 @default.
• W2057142441 hasConceptScore W2057142441C159654299 @default.
• W2057142441 hasConceptScore W2057142441C197934379 @default.
• W2057142441 hasConceptScore W2057142441C203014093 @default.
• W2057142441 hasConceptScore W2057142441C22070199 @default.
• W2057142441 hasConceptScore W2057142441C2775948956 @default.
• W2057142441 hasConceptScore W2057142441C2777351567 @default.
• W2057142441 hasConceptScore W2057142441C2778782382 @default.

• next